financetom
Business
financetom
/
Business
/
Xiaomi launches YU7 priced from 253,500 yuan, challenging Tesla's Model Y
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Xiaomi launches YU7 priced from 253,500 yuan, challenging Tesla's Model Y
Jun 26, 2025 7:12 AM

BEIJING, June 26 (Reuters) - Chinese EV and smartphone

maker Xiaomi ( XIACF ) on Thursday priced its new electric YU7

SUV 10,000 yuan ($1,395) cheaper than Tesla's Model Y, stepping

up the challenge to the U.S. firm in the world's largest auto

market.

The base model of the YU7 starts from 253,500 yuan

($35,364), with the more premium models YU7 Pro and YU7 Max

priced at 279,900 and 329,900 yuan respectively.

Xiaomi ( XIACF ) will take orders for all three models from Thursday

night.

The Model Y, which was China's best-selling SUV in May,

retails from 263,500 yuan in China.

Xiaomi's ( XIACF ) CEO and founder Lei Jun has said he wants the YU7

to challenge the Model Y and analysts say it is well placed to

take on the Tesla vehicle's dominance. Other rivals include

Zeekr's 7X and Li Auto's L6.

The YU7 has a driving range of up to 835 kilometres (519

miles) per charge, versus the redesigned Model Y that was

launched in January with a range of up to 719 kilometres.

($1 = 7.1684 Chinese yuan renminbi)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved